![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, September 05, 2017 4:12:43 PM
If they get a tentative approval and then win the court battle, then we really have something and the stock will jump. Of course, Purdue can tell if they are not going to win and would likely settle first.
I like the fact they are strengthening the patents surrounding PODRAS as I think this is where the really big money is.
They did not say anything wonderful about Seroquel and Focalin sales. I think they would have if there was something to talk about on that front.
There was nothing said about cash or the balance sheet. That is all important and an unfortunate omission. They have rising legal costs, rising testing costs and, as best we know, not a lot of cash. Either our new CFO delivers cash from some sale of product rights or some partnership agreement or there would seem to be a high likelihood of some type of new equity being sold.
Recent IPCI News
- Suspension de la négociation par l'Organisme canadien de réglementation des investissements - IPCI • PR Newswire (Canada) • 03/06/2024 12:55:00 PM
- Canadian Investment Regulatory Organization Trading Halt - IPCI • PR Newswire (Canada) • 03/06/2024 12:51:00 PM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM